
浏览全部资源
扫码关注微信
1.中国中医科学院 中药研究所 中药质量控制技术国家工程实验室,北京 100700
2.广州医药集团有限公司,广州 510103
3.广州白云山和记黄埔中药有限公司,广州 510515
王智民,研究员,从事中药化学和质量评价研究,Tel /Fax:010-84014128,E-mail:zhmw123@ 263.net
刘晓谦,研究员,从事中药制剂和质量评价研究,Tel/Fax:010-84017310,E-mail:lianyu1127@126.com
收稿日期:2021-07-26,
网络出版日期:2021-08-05,
纸质出版日期:2022-01-05
移动端阅览
王智民,刘菊妍,王德勤等.关于经典名方研发的一些重要关键信息和科学问题的几点看法[J].中国实验方剂学杂志,2022,28(01):212-217.
WANG Zhi-min,LIU Ju-yan,WANG De-qin,et al.Views on Key Technical Problems in Research and Development of Famous Classical Formulas[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(01):212-217.
王智民,刘菊妍,王德勤等.关于经典名方研发的一些重要关键信息和科学问题的几点看法[J].中国实验方剂学杂志,2022,28(01):212-217. DOI: 10.13422/j.cnki.syfjx.20211852.
WANG Zhi-min,LIU Ju-yan,WANG De-qin,et al.Views on Key Technical Problems in Research and Development of Famous Classical Formulas[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(01):212-217. DOI: 10.13422/j.cnki.syfjx.20211852.
笔者拟针对中药经典名方研发中的重大关键技术问题进行分析,以期为经典名方的开发提供参考。首先,针对长期困惑行业的古代计量换算为现代计量单位的问题进行全面的阐述,认为“一两=3 g”更为合适。其次,针对从传统砂锅煎制的基准样品(ABS-C)的质量向实验室工艺、中试工艺、工业生产上的质量一致性转化的评价给出了评价模型和原则,一致性评价模型为
ξ
ABS-X
=
K
1
(
Q
1
ABS-X
/
Q
1
ABS-C
)+
K
2
(
Q
2
ABS-X
/
Q
2
ABS-C
)+……+
K
i
(
Q
i
ABS-X
/
Q
i
ABS-C
)=∑
K
i
(
Q
i
ABS-X
/
Q
i
ABS-C
)(
i
=1,2,3……
n
),式中ABS-X表示实验室基准样品(ABS-L),中试ABS-C(ABS-mP)或产业化生产ABS-C(ABS-P);
ξ
ABS-X
为ABS-L,ABS-mP,ABS-P各级工艺与ABS-C的质量一致率,
K
i
表示各质量评价指标(
i
)的权重,
Q
i
ABS-X
为ABS-L,ABS-mP,ABS-P的各质量评价指标(
i
)数据,
Q
i
ABS-C
为经典名方ABS-C中各质量评价指标的数据(或均值)。再次,针对药效物质不清楚药味的质量控制,应深入开展其化学成分研究,必要时,应依据经典名方的主要功效或适应症所对应的体外测定指标等开展生物测定法研究。最后,对于一些药味的特殊炮制,其炮制方法、工艺、饮片标准存在难以制定的问题,建议应深入梳理其特殊炮制方法的科学内涵和历史沿革,总结其工艺特性,模拟现代炮制工艺和路线,进而制定相应炮制方法和质量标准。
In this paper, the key technical problems in the research and development of famous classical formulas are analyzed. Firstly, the puzzled problem for a long-time, which is conversion relationship from medicinal metrology of Han dynasty (HD) to that of modern (gram,g), is comprehensively expounded that one
Liang
(两) of HD=3 g is more appropriate. Secondly, the model and principles of quality consistency evaluation are given for the transformation from the quality of authoritative basic sample prepared by casserole (ABS-C) to the quality consistency in Laboratory process, pilot-scale process and industrial production. The consistency evaluation model is
ξ
ABS-X
=
K
1
(
Q
1
ABS-X
/
Q
1
ABS-C
)+
K
2
(
Q
2
ABS-X
/
Q
2
ABS-C
)+……+
K
i
(
Q
i
ABS-X
/
Q
i
ABS-C
)=∑
K
i
(
Q
i
ABS-X
/
Q
i
ABS-C
)(
i
=1,2,3……
n
). In the formula, ABS-X means laboratory reference sample ABS-C (ABS-L), pilot-scale ABS-C (ABS-mP) or industrial production ABS-C (ABS-P),
ξ
ABS-X
means the quality consistency rate or similarity degree of ABS-L, ABS-mP and ABS-P processes with ABS-C,
K
i
means the weight of each quality evaluation index (
i
),
Q
i
ABS-X
is the data of
i
in ABS-L, ABS-mP, ABS-P samples, and
Q
i
ABS-C
is the data (or mean) of
i
in ABS-C sample. Thirdly, in order to control the quality of the herbal medicines whose active ingredients were unknown, their chemical constituents should be studied deeply, and if necessary, the bioassay research should be carried out according to the main efficacy or indication of famous classical formulas. Finally, for the special processing of some herbal medicines, it is difficult to formulate the processing method, technology and standard of prepared slices. It is suggested that the scientific connotation and historical evolution of the special processing method should be thoroughly sorted out, and its technological characteristics are summarized, the modern processing technology and production processes are simulated, and then the corresponding processing methods and quality standards are formulated.
国家中医药管理局 , 国家药品监督管理局 . 关于发布《古代经典名方关键信息考证原则》《古代经典名方关键信息表(7首方剂)》的通知 [EB/OL].( 2020-11-10 )[ 2021-07-01 ]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20201111091109170.html https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20201111091109170.html .
邓中甲 . 方剂学 [M]. 北京 : 中国中医药出版社 , 2003 .
李宇航 , 郭明章 , 孙燕 , 等 . 仲景方用药度量衡古今折算标准研究 [J]. 北京中医药大学学报 , 2010 , 33 ( 9 ): 597 - 600 .
仝小林 , 崔勿骄 , 崔新育 , 等 . “神农秤”质疑 [J]. 中华医史杂志 , 1996 , 26 ( 4 ): 251 - 252 .
ZHA L H , HE L S , LIAN F M , et al . Clinical strategy for optimal traditional Chinese medicine (TCM) herbal dose selection in disease therapeutics:expert consensus on classic TCM herbal formula dose conversion [J]. Am J Chin Med , 2015 , 43 ( 8 ): 1515 - 1524 .
日本厚生省药务局 . 现代日本汉方处方手册 [M].顾旭平,译. 上海 : 上海中医学院出版社 , 1989 .
徐立鹏 , 穆兰澄 , 郭允 , 等 . 论药材含水量对经方剂量折算的影响 [J]. 世界中医药 , 2015 , 10 ( 5 ): 784 - 787,792 .
宋佳 , 傅延龄 . 从明代医家临床用药剂量谈经方剂量变化趋势 [J]. 中医杂志 , 2012 , 53 ( 18 ): 1531 - 1533 .
古求知 , 柳长华 . 古方今用剂量问题探索 [J]. 辽宁中医药大学学报 , 2011 , 13 ( 9 ): 111 - 112 .
王智民 , 洪玉梅 , 王维皓 , 等 . 吴茱萸配方颗粒等效性研究 [J]. 中国中药杂志 , 2007 , 32 ( 12 ): 1149 - 1154 .
王锦玉 . 麻杏石甘汤配方颗粒的研究 [D]. 北京 : 中国中医科学院 , 2005 .
洪玉梅 . 吴茱萸炮制工艺及质量标准规范化研究和吴茱萸配方颗粒规范化研究 [D]. 北京 : 中国中医科学院 , 2005 .
洪玉梅 , 王维皓 , 王智民 , 等 . 甘草制吴茱萸炮制研究 [J]. 中国中药杂志 , 2008 , 33 ( 8 ): 884 - 888 .
0
浏览量
23
下载量
8
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621